Shares of Calmare Therapeutics Inc (OTCMKTS:CTTC) passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.12 and traded as low as $0.08. Calmare Therapeutics shares last traded at $0.13, with a volume of 8,879 shares traded.

The stock has a 50-day moving average price of $0.12 and a two-hundred day moving average price of $0.13.

Calmare Therapeutics Company Profile (OTCMKTS:CTTC)

Calmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain.

Featured Story: Pattern Day Trader

Receive News & Ratings for Calmare Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calmare Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.